Coronary venous therapy to improve microvascular dysfunction

Area of Science:

• Cardiovascular Physiology
• Interventional Cardiology

Background:

• Coronary circulation comprises epicardial, microvascular, and venous compartments, each influencing vascular resistance.
• Cardiologists often focus on epicardial diseases, neglecting the microvascular and venous systems, which are significant contributors to ischemia.
• Coronary microvascular disease is an emerging cause of ischemia, yet understanding and classification remain incomplete, with no specific therapies available.

Purpose of the Study:

• To review the role of coronary sinus interventions in treating ischemic heart disease.
• To highlight the importance of coronary microvascular disease and venous circulation in managing ischemic heart disease.
• To discuss the potential of increasing coronary venous pressure for improving coronary perfusion.

Main Methods:

• Literature review of studies on coronary circulation, microvascular disease, and coronary sinus interventions.
• Analysis of diagnostic tools and their impact on studying coronary microcirculation.
• Examination of invasive techniques, including surgical and catheter-based, for coronary sinus interventions.

Main Results:

• Coronary microcirculation is increasingly recognized as a source of ischemia, necessitating advanced diagnostic tools.
• Coronary sinus interventions aim to improve coronary perfusion by increasing venous pressure and redistributing blood flow.
• Evidence suggests that modulating venous pressure may enhance coronary perfusion, offering a new therapeutic avenue.

Conclusions:

• Coronary microvascular disease and venous circulation are critical, yet often overlooked, components of coronary circulation.
• Coronary sinus interventions represent a promising approach for managing ischemic heart disease, particularly concerning microvascular dysfunction.
• Further research is needed to fully elucidate the complexity of coronary venous circulation and optimize therapeutic strategies.